Neoadjuvant Chemotherapy Effect on Predictive Value of Sentinel Lymph Node Biopsy using Single Method Methylene Blue in Breast Cancer Patients at Low-resource Country

Authors

  • Muhammad David Perdana Putra Department of Surgery, Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia
  • Kristanto Yuli Yarso Department of Surgery, Oncology Division, Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia
  • Brian Wasita Department of Pathology Anatomy, Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2021.5715

Keywords:

Neoadjuvant chemotherapy, Predictive value, Sentinel lymph node biopsy, Methylene blue, Low-resource country

Abstract

AIM: This study aimed to examine the application of neoadjuvant chemotherapy (NAC) effect on sentinel lymph node biopsy (SLNB) using single method methylene blue 1% in breast cancer patients at low-resource country.

METHODS: This analytical observational study employed a retrospective case–control approach. The total sampling method was used by involving the entire population of Stage-I and -II breast cancer patients after performed core biopsy or open biopsy with clinically negative axillary lymph nodes that had performed SLNB and axillary lymph nodes dissection at several hospitals in Surakarta from January to May 2020. The descriptive data were presented in the frequency table. Sensitivity, specificity, positive predictive value, negative predictive value (NPV), and diagnostic values were reported with 95% confidence of interval (CI).

RESULTS: From a total of 161 patients, 100 patients were given NAC. The identification rate of the non-NAC was 91.3% and the NAC group 80.6%. Non-NAC group obtained a false-negative rate of 24.4% with NPV of 94.4% (95% CI 85–100), while the false-negative rate of the NAC group was 10.8% with NPV of 74% (95% CI 65–80).

CONCLUSIONS: NAC with single method methylene blue 1% injection in SLNB can reduce the identification and false-negative rates in breast cancer patients.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast cancer, Version 3.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(4):452-78. PMid:32259783

Papathemelis T, Jablonski E, Scharl A, Hauzenberger T, Gerken M, Klinkhammer-Schalke M, et al. Sentinel lymph node biopsy in breast cancer patients by means of indocyanine green using the karl storz VITOM® fluorescence camera. Biomed Res Int. 2018;2018:6251468. https://doi.org/10.1155/2018/6251468 PMid:29780827

Ramírez-Nava G, Santos-Cuevas C, Ferro-Flores G, Ocampo- García B, Chairez I, Gómez-Argumosa E, et al. Hybrid (2D/3D) dosimetry of radiolabeled gold nanoparticles for sentinel lymph node detection in patients with breast cancer. Contrast Media Mol Imaging. 2020;2020:2728134. https://doi.org/10.1155/2020/2728134 PMid:32489332

Lee SA, Lee HM, Lee HW, Yang BS, Park JT, Ahn SG, et al. Risk factors for a false-negative result of sentinel node biopsy in patients with clinically node-negative breast cancer. Cancer Res Treat. 2018;50(3):625-33. https://doi.org/10.4143/crt.2017.089 PMid:28759990

Faisal M, Sayed MG, Antonious K, Bakr AA, Farag SH. Prevention of lymphedema via axillary reverse mapping for arm lymph-node preservation following breast cancer surgery: A randomized controlled trial. Patient Saf Surg. 2019;13:35. https://doi.org/10.1186/s13037-019-0217-1 PMid:31807140

Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American college of surgeons oncology group trial Z0011. J Clin Oncol. 2007;25(24):3657-63. https://doi.org/10.1200/jco.2006.07.4062 PMid:17485711

Langer I, Guller U, Berclaz G, Koechli OR, Schaer G, Fehr MK, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: A prospective Swiss multicenter study on 659 patients. Ann Surg. 2007;245(3):452-61. https://doi.org/10.1097/01.sla.0000245472.47748.ec PMid:17435553

Rubio IT. Sentinel lymph node biopsy after neoadjuvant treatment in breast cancer: Work in progress. Eur J Surg Oncol. 2016;42(3):326-32. https://doi.org/10.1016/j.ejso.2015.11.018 PMid:26774943

Mamounas EP, Anderson SJ, Dignam JJ, Bear HD, Julian TB, Geyer CE, et al. Predictors of locoregional recurrence after neoadjuvant chemotherapy: Results from combined analysis of national surgical adjuvant breast and bowel project B-18 and B-27. J Clin Oncol. 2012;30(32):3960-6. https://doi.org/10.1200/jco.2011.40.8369 PMid:23032615

Fan F. Evaluation and reporting of breast cancer after neoadjuvant chemotherapy. Open Pathol J. 2009;3(2):58-63.

Cohen LF, Breslin TM, Kuerer HM. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol. 2000;24(9):1266-72. https://doi.org/10.1097/00000478-200009000-00010 PMId:10976701

Zurrida S, Veronesi U. Milestones in breast cancer treatment. Breast J. 2015;21(1):3-12. https://doi.org/10.1111/tbj.12361 PMid:25494903

Widodo I, Dwianingsih EK, Triningsih E, Utoro T, Soeripto S. Clinicopathological features of Indonesian breast cancers with different molecular subtypes. Asian Pac J Cancer Prev. 2014;15(15):6109-13. https://doi.org/10.7314/apjcp.2014.15.15.6109 PMid:25124582

Brahma B, Putri RI, Karsono R, Andinata B, Gautama W, Sari L, Haryono SJ. The predictive value of methylene blue dye as a single technique in breast cancer sentinel node biopsy: A study from Dharmais cancer hospital. World J Surg Oncol. 2017;15(1):41. https://doi.org/10.1186/s12957-017-1113-8 PMid:31205300

Borgstein PJ, Meijer S, Pijpers RJ, van Diest PJ. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: Echoes from the past and the periareolar blue method. Ann Surg. 2000;232(1):81-9. https://doi.org/10.1097/00000658-200007000-00012 PMid:10862199

Shimazu K, Tamaki Y, Taguchi T, Takamura Y, Noguchi S. Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery. 2002;131(3):277-86. https://doi.org/10.1067/msy.2002.121378 PMid:11894032

Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA. 2011;305(6):569-75. https://doi.org/10.1001/jama.2011.90 PMid:21304082

Soebhi T, Yarso KY, Sobri FB, Budhi IB. Methylene blue absorption in sentinel lymph node biopsy for early breast cancer after neoadjuvant chemotherapy. Asian Pac J Cancer Prev. 2020;21(6):1767-71. https://doi.org/10.31557/apjcp.2020.21.6.1767 PMid:32592376

Downloads

Published

2021-02-26

How to Cite

1.
Putra MDP, Yarso KY, Wasita B. Neoadjuvant Chemotherapy Effect on Predictive Value of Sentinel Lymph Node Biopsy using Single Method Methylene Blue in Breast Cancer Patients at Low-resource Country. Open Access Maced J Med Sci [Internet]. 2021 Feb. 26 [cited 2021 May 9];9(B):191-5. Available from: https://oamjms.eu/index.php/mjms/article/view/5715